GENERAL CONSIDERATIONS
In the present state of our knowledge, the problems concerned with cellular resistance to viral infection appear to fall into two main categories. The first relates to the surface properties of viruses and cells that permit the initial act of virus attachment on and penetration into cells. The second, and far more complex problem, or rather series of problems, is the nature and control of the intracellular events in virus replication, events which lead either to death of the infected cell or its recovery. The present discussion is concerned largely with this latter facet of cellular resistance: the intrinsic capacity of some cells and, by extension, some organisms to overcome the effects of viral infection. To limit the scope of the discussion even further, attention will be focused on the potential relationship between endogenous production of interferon by cells, the capacity of those cells to recover from viral infection, and their subsequent resistance to superinfection by the same or other viruses.
A word about the surface interactions of viruses and cells is perhaps in order, partially by 1 This review was originally presented at "A Symposium on the Biological Aspects of Viruses in Relation to Medical Problems," held 13 way of introduction and mainly because fruitful studies of cellular resistance have been directed to this phase of the infectious process. The advances in this field derive essentially from the development of techniques for isolating and maintaining relatively homogeneous suspensions of viruses and cells. Kinetic studies of virus adsorption reveal that the initial factors in cellular susceptibility to infection are the surface receptor sites of the cell and virus. Mutant forms of viruses or cells deficient in surface receptors may arise, which serves to emphasize the longsuspected concept that the first stages of infection are under genetic control of nucleic acids of virus and cell.
Prospects have never been brighter for more meaningful studies of the first stages of cellular infection by viruses. Much of the impetus for this work stems from new techniques for analyzing virus structure by electron microscopy (40) and X-ray diffraction (54) . It now seems clear that viruses differ significantly from each other not only in structure but in function of their morphological constituents. Certain virions (extracellular virus particles) possess capsids with protein subunits (capsomeres) arranged in cubic symmetry, often icosahedral, around a nucleic acid core. The architecture of other virions is helical with protein subunits arranged sequentially in the form of a long spiral chain. In addition, the larger and more complex virions are encased in an envelope apparently derived from cell constituents. With this background it is easier to conceptualize the separate processes of virion attachment to cell surfaces, penetration into the cell, and dissociation of virus nucleic acid from its protein component inside the penetrated cell. Attachment of the cubic poliovirus, for example, appears to lead to productive infection when the nucleocapsid dissociates into constituent ribonucleic acid (RNA) and protein at the cell surface or after penetration (51, 60) . Attachment of the helical myxovirus virion also leads to penetration of the internal nucleocapsid but apparently the envelope is left behind on the cell surface (42) . Observations such as these, coupled with kinetic studies of temperature effects (59) , are rapidly laying to rest the erroneous concept that penetration of animal viruses is a purely passive process. Parenthetically, findings such as these have also prompted the suggestion put forth by Herriott (31) that extracellular virus may sometimes exist in the native state as naked nucleic acid devoid of its usual protein coat. Presumably, the unavailability of cellular surface receptors would pose no problem to virus nucleic acid in gaining access to the cell protoplasm. Moreover, the thesis goes, such proteinless viruses could ostensibly persist in the tissues oblivious to host antibody. Of course, and this is conceded to be a difficult point to resolve, the barriers to virus nucleic acid are at least as formidable as the barriers to virus protein, not the least of which is the presence in the tissues of abundant nucleases. Herriott's theory of viral infectivity and virus persistence in resistant hosts is intriguing, but it would appear to be on less firm ground than some of the proposals offered herein. Far more experimental data are required before serious consideration can be given to the concept that penetration of naked virus nucleic acid into cells represents a valid mechanism of infection in nature.
It is apparent that availability of surfaoe (and microsomal) receptors for capsid attachment is only the first line of a cell's defense (37) . Once dissociated inside the cell, one virus nucleic acid may find conditions favorable for replication and another may not. It seems safe to assume that the intracellular determinants of resistance to infection are also distinctive genetic characteristics of each cell and each virus. Having said this, we are almost at the limit of our knowledge. In the past few years, however, considerable progress has been made in devising reliable methods for studying nucleic acid and protein metabolism of cells infected with animal viruses (10, 20) . Even more recently, the use of selective inhibitory substances has permitted further dissection of intracellular events in the infectious process. These studies have revealed striking differences among viruses that relate to mechanisms of infection and cellular defense. For example, the antibiotic actinomycin D, which inhibits cellular RNA synthesis, suppresses replication of the deoxyribonucleic acid (DNA) vaccinia virus but does not affect growth of the RNA Mengo virus (64) . This suggests that vaccinia DNA synthesis is dependent on cellular RNA for formation of enzyme precursors. The genetic material of Mengo virus, on the other hand, is a distinctive species of RNA that does not require cellular RNA as an intermediary for replication. Similar studies with halogenated pyrimidines as metabolic antagonists of cellular and virus DNA (17) also indicate that RNA of poliovirus is independent of cellular DNA (68 Substances with at least some of the properties of interferon are detected under so many conditions of virus-cell interaction that it appears safe to assume that interferons are ubiquitous. One line of reasoning would hold that, being ubiquitous, interferons are probably important. The credit for most of these discoveries and many of these concepts belongs to others, but some are derived from our own laboratory experiences. Hence, our own data will be presented, when available and pertinent, without pretense of treating the subject broadly, as was attempted previously (75) . A comprehensive review and bibliography on interferons were published recently by Ho (35) .
NATURE OF INTERFERON
It is necessary to digress for a moment from the main problem of endogenous interferon in order to reach a working definition of interferon, a term which will be used generically without citing justification. It should be borne in mind, however, that no one has taken the position that interferons, from whatever source, are necessarily identical. In fact, the sometimes striking biological specificity of some interferons for the species in which they were prepared has been reported frequently (72, 76) . Of course, our knowledge, such as it is, is limited to exogenous interferons (reviewed by Ho, 35) .
As previously reported (76) , an interferon that has been studied in our laboratory is produced by infecting allantoic cells of chick embryos with fully infectious influenza virus. These cells liberate both virus progeny and interferon into the allantoic fluid. The bulk of the virus can be removed by centrifugation and the supernatant fluid serves as our source of interferon. Interferons prepared in this way are readily detected and titrated by their capacity to inhibit plaque formation of Eastern equine encephalitis (EEE) virus or other viruses on monolayer cultures of chick embryo cells.
Among the most interesting physicochemical properties of interferons are their susceptibility to proteolytic enzymes, and their relative insusceptibility to heat, viral antibody, nucleases, alkali, and acid. This last property of resistance to inactivation by acid has been widely used as a criterion for whether an interfering substance is indeed an interferon. The method, as originally proposed by Lindenmann et al. (56) , simply entails dialysis in the cold against a buffer at pH 2, followed by further dialysis back to neutrality. It has been assumed that this treatment rids the preparation of contaminating virus. This is not always the case. We have found, for example, that quite a few plaque-forming units (PFU) of EEE virus can persist at pH 2 for 72 hr (77). It is strongly advised, therefore, that both centrifugation and acid dialysis should be used before assuming that a putative interferon preparation contains no significant amounts of viable or nonviable interfering virus.
Burke (6) has made the only significant studies of the chemical nature of interferon that have been published to date. He found that a chick embryo interferon purified 20-fold by column chromatography is electrophoretically homogeneous, has a sedimentation coefficient of 4.77, and is estimated to have a molecular weight of 63,000. Chemical analysis of this preparation, in support of biological data, reveals that this interferon is a protein with an isoelectric point between pH 4.5 and 5, and that it contains about 1 % carbohydrate and no significant amount of nucleic acid. This is about the extent of our knowledge of the physicochemical properties of a single interferon.
Kinetic analyses of the mechanism of interferon action have been only partially successful (76) . However, several pertinent facts have emerged from these and other studies (35) . The first is that exogenous interferon does not inactivate extracellular virus, nor does it inactivate extracellular infectious virus RNA (34, 61, 26) . The obvious implication is that interferon acts on the cell rather than on the virus. Evidence for interferon-cell interaction has been obtained by studying the rate of interferon uptake by cells in the absence of virus, and by comparing this with the rate at which these VOL. 27, 1963 75 (14) , and Grossberg and Holland (26) . These investigators found that interferon also inhibits virus multiplication in cells infected with naked RNA of poliovirus and equine encephalitis viruses. Thus, the evidence seems clear that the site of interferon action is inside the cell. Moreover, recent studies (14) suggest that interferon blocks synthesis of viral RNA, as determined by cold phenol extraction of infected cells. What we lack is an explanation for the mechanism of this action. The most popular thesis at the moment is that interferon uncouples mitochondrial or nuclear oxidative phosphorylation, thus depriving the virusproducing machinery of the cell of the energy required to make one or more of the constituent parts of mature virus (48, 50 (77) . To this end, monolayer cultures of approximately 2 X 107 chick embryo cells were infected at 37 C with 2 X 108 PFU of EEE virus. The tissue culture fluid was sampled at intervals thereafter to assay its content of virus and interferon. It was also considered advisable to study a less lethal infection under comparable conditions. We had noted previously that plaque formation, multiplication, and cytopathic effect of EEE virus are all appreciably slower at 30 than at 37 C. Therefore, we postulated that less virus and more interferon might be produced under the conditions of a less virulent infection at lower temperature. The results of this experiment are shown by the single-cycle growth curves of EEE virus reproduced in Fig. 1 . As anticipated, virus multiplied more rapidly at 37 C and higher titers were achieved. Also, cytopathic changes at 30 C lagged at least 24 36 hr, at which time interferon was first detectable. On reflection it was apparent that we were studying the wrong thing. Presumably, HA and interferon could simply be piling up in the allantoic fluid, precluding any comparison of temporal relationships in their formation. In effect, we had been measuring the cumulative content of HA and interferon, which in no way accurately reflects the events that transpire in the cells at each stage of infection.
Therefore, the experiments were repeated (77), using chick embryos infected with approximately 105 EID5o of the WS strain of influenza virus. At intervals of 12 hr after infection, the allantoic fluids were poured off, the eggs were de-embryonated, and chorioallantoic membranes were collected intact. Individual membranes were then washed thoroughly to remove extracellular virus and interferon, the cells disrupted by alternate freezing and thawing, and the cell lysates assayed for HA and interferon. In this way comparative data were obtained on the--content of HA and interferon inside the same cells at intervals after infection.
The results of one such experiment are shown in Fig. 2 . Clearly, the capacity of allantoic cells to make viral HA was maximal in 24 to 36 hr and declined rapidly thereafter. In fact, most of the membranes were completely devoid of HA within 60 hr despite very high titers in the allantoic fluids of the same eggs. At the time that cellular HA titers began to decline, 36 to 48 hr after infection, interferon first appeared in these cells. The subsequent rise in interferon titer was directly associated with disappearance of cellular HA.
It is tempting to postulate that the decline in virus titer is a direct function of the onset of interferon production by the cells. It is possible, ot course, that these events are unrelated, but the temporal correspondence strongly suggests that the allantoic cells stop making virus when they start making interferon. Moreover, it seems logical to assume that the tremendous quantities of virus produced during the first few cycles of virus replication would lead to infection of virtually every allantoic cell in a membrane. The conclusion seems inescapable that the same cell that was synthesizing virus HA early in the infection is diverted to interferon synthesis, and that production of these two cell products is mutually exclusive.
Another parameter of the infectious process was measured using these same membranes (77) . The disrupted cells were also tested for their content of influenza S antigen, as measured by complement fixation with S antibody prepared in guinea pigs by the method of Lief et al. (55) . In brief, the results of these analyses showed that S antigen continued to form for at least 72 hr. Therefore, the cells appear to retain their capacity to make one component of influenza virus even in the presence of large quantities of interferon. It should be mentioned, however, that these studies are not as convincing as those concerned with HA production, because free S antigen is released from cells much more slowly.
An even more fruitful approach to the question of a relationship between cellular resistance and interferon production emerges from the recent work of Gresser and Enders (25) (41) , which indicate that a state akin to immunological tolerance (62) occurs in mice infected at or before birth with lymphocytic choriomeningitis (LCM) virus. This virus persists in mice throughout their lives, presumably because they do not recognize the antigenic stimulus as being foreign and, hence, form no antibody. These persistently infected animals retain in their tissues a quantity of virus sufficient to kill thousands of virgin adult mice but remain relatively healthy themselves. Not only do these animals resist the lethal effects of the carried LCM virus, they also resist challenge with a large dose of the same virus. It seems improbable that this resistance to the persistent and the superinfecting LCM virus is a form of immunological tolerance. It is just as plausible to assume that the persistent LCM virus acts as an interfering agent.
To test this hypothesis, persistent LCM infection was established in mice by injecting them at birth by the method suggested by Hotchin (41, personal communication) and with a virus strain provided by him. Rearing healthy animals chronically infected with LCM virus has not been an easy task in our hands; only relatively few neonatally infected mice survive into adulthood. However, all survivors developed viremia which was still demonstrable 7 months after birth, the duration of our period of observation. When they were 1 month old, a group of persistently infected mice and a group of uninfected controls, weaned from identical litters, were challenged with EEE virus. The mice infected at birth with LCM virus were less susceptible to EEE virus as evidenced by fewer and later deaths (79) .
After these studies were begun, it was learned that Traub (70) had already done similar experiments and demonstrated unequivocable resistance to EEE virus in mice congenitally infected with LCM virus. There is little question that these data represent examples of viral interference in mice with persistent infections. The crucial question, of course, is whether these mice are producing interferon as well as LCM virus. We have been unsuccessful, thus far, in demonstrating interferon in the brains and lungs of these resistant mice.
In addition to the studies in mice, we have been able to establish persistent infections with LCM virus in cultures of L cells and have observed that these cultures resist the cytopathic effect of VS virus (79) . Once again, however, the problem has been our inability to demonstrate the presence of interferon. Our failure to do so may, to a large extent, be a technical problem.
Presumably, if interferon were produced at a slow rate in mice and tissue cultures infected with LCM virus, it might be difficult to demonstrate its presence for two reasons. The bio-assay method used for its detection may be insufficiently sensitive, and, more importantly, we are examining the tissues or culture fluids at a single point in time, whereas the effects of endogenous interferon are undoubtedly cumulative.
INTERFERON PRODUCTION IN ANIMALS
Certain difficulties arise when attempts are made to translate information on studies of interferon production in cell cultures or allantoic membranes into mechanistic concepts of cellular resistance to infection in adult animals. Obviously, tissues of intact animals cannot be so readily manipulated as can the confined and controllable area of a monolayer tissue culture or chorioallantoic membrane. Witness the problems encountered in demonstrating interferon production in animals, as alluded to in the preceding studies of LCM virus. Neverthe-less, two facts are apparent: interference is readily demonstrable at localized tissue sites (74) , and animals do produce interferon (33, 47) . It is, of course, a long step to assume that these isolated findings are related to mechanisms of cellular resistance and recovery from infection. One would like to know, in particular, whether tissue resistance really increases during the course of viral infection, and, if so, whether it speeds the recovery of the host. Also, would interferon production at a local tissue site be of any value to the host in the face of a systemic viral infection?
Hitchcock and Isaacs (32) devised an experiment to provide information about the latter question. They took advantage of the knowledge that influenza virus can cause a nonlethal pneumonia in mice without significant virus dissemination to other tissues. At the same time, they observed that interferon is produced in the lung during the course of infection. Their studies demonstrated a clear, albeit slight, increase in resistance to encephalitis caused by peritoneal challenge with Bunyamwera virus. We have confirmed their results by using the more virulent WS virus as an interfering agent against challenge with EEE virus. However, under the conditions of our experiments, it was necessary to induce a near-lethal pneumonia to detect any resistance whatsoever (Wagner, unpublished data).
The enhanced capacity of mice with influenza pneumonia to survive challenge with EEE virus was significant, but barely so. It should be noted, however, that many of the animals infected with influenza virus died with complete pulmonary consolidation. In agreement with the experiments reported by Hitchcock and Isaacs (32), we have also found interferon in the lungs of resistant mice, but far less consistently than they did. The most reasonable explanation for these findings, as yet unproven, is that interferon produced in response to the viral infection of lung diffuses into the blood stream, thence is transported to cells of the nervous system rendering them resistant to the encephalitis virus.
Interference at a distant site (7) has also been studied in chick embryos, using more closely related viruses as the interfering and superinfecting pair (27). Use was made of a convenient and readily measurable response to infection, hemorrhagic encephalitis in chick embryos infected intravenously with the NWS strain of influenza virus (39) . Allantoic infections were established with different strains of influenza virus, providing an excellent supply of endogenous interferon, and the chick embryos were challenged by intravenous injection 24 hr later with 300 LD5o of NWS virus. In several such studies, the incidence of death and cerebral hemorrhages was reduced by 80%. The protective effect was greatest when the allantoic infection had been established for some time previously, a finding which coincides with the data on delayed production of interferon by allantoic cells. Once again, we were able to demonstrate interferon in allantoic fluid but not in the blood of resistant embryos, which leaves in the realm of conjecture the thesis that interferon diffuses out of the allantoic sac and protects the endothelial cells of the brain against infection with NWS virus. This negative finding may well be simply a reflection of the relatively brief time that interferon is in transit through the circulation before it is fixed by the cells.
Barron and Isaacs (3) made the interesting suggestion that varying degrees of "sensitivity" to the action of exogenous interferon may account for variations in the lethal effect of viruses in chick embryos at different ages. Their conclusions are also based on previously published studies (45) which indicate that allantoic membranes removed from young embryos produce less virus and less interferon than do membranes of older embryos. Furthermore, virus production by membranes of older embryos was shown to be more readily suppressed by exogenous interferon. Their hypothesis seems to have considerable merit, but further data are required to make it entirely convincing. Nevertheless, studies such as these provide means for approaching the interesting problem of age and susceptibility to viral infection. In this regard it is noteworthy that adult mice produce interferon and survive cerebral infection with the arbor A virus O'nyongnyong, whereas infant mice rapidly succumb (33) .
The question most pertinent to our discussion is whether interferon produced locally in host tissues serves to control infection by the virus that stimulated its production. (43) pointed out, it is certainly more likely that the recovery of the mouse from acute influenza pneumonia is attributable to interferon rather than to antibody formation. As emphasized by other investigators (21, 18) , the antibody response to primary infection, and perhaps even to reinfection (71) , often occurs too late to influence significantly the course of acute viral infections. In an interesting extension of this thesis to a chronic viral disease, Allison (1) raised the question whether disappearance of polyoma virus from polyoma tumors is due to interferon production rather than to erratic antibody responses in tumor-bearing animals (65) . It would, of course, be erroneous to assume that endogenous production of interferon is the only factor in cellular resistance. Contrary evidence can be cited. Vainio, Gwatkin, and Koprowski (73) investigated the possibility that the genetic differences in the capacity of inbred strains of mice to resist infection with West Nile virus might be attributable to deficient interferon production. They found that brains of susceptible animals produced more, not less, interferon than did brains of genetically resistant animals. Similar observations are cited above in the discussion on interferon production in lethally and nonlethally infected cell cultures. The conclusion of Vainio and his colleagues that the capacity to survive encephalitic infection is unrelated to interferon production certainly seems valid. However, it is quite interesting that mice resistant to West Nile virus are able to make any interferon at all. The extraordinarily low titers of virus in the brains of resistant animals (maximally, 6 .5 x 103 PFU/g) might have been considered insufficient to stimulate any interferon production. In other words, if the cells of an animal make little virus initially, one would expect them to make little interferon later in the course of infection. It would be of interest to compare the capacity of susceptible and resistant mice to produce interferon in response to identical doses of noninfectious irradiated West Nile virus. Of greater significance, perhaps, is the possibility that brains of resistant and susceptible mice may be differentially susceptible to the action of the interferon that is produced, regardless of the amount that is produced.
RELATION TO MEDICAL PROBLEMS The reviewer undoubtedly runs a risk by extending speculations on the biology of interferon into the realm of its relation to medical problems. Original reservations about attempting to bridge the gap between the cell and the human organism have been allayed by the knowledge that some of my colleagues in this field have succumbed to the same temptations (4). The priority for many of these concepts is theirs, and our disagreements are minor.
Any remaining inhibitions have vanished in the knowledge that commercial production of interferon is in the offing and reports have been published of successful trials on human subjects (52, 67) . The writer has no competence to judge whether the engineering problems involved in mass production, purification, and concentration can be solved. The obstacles do not seem insurmountable. Even the problem of species specificity, which was once viewed as a major deterrent, has been partially resolved by the demonstration that interferon produced by monkey kidney cells effectively suppresses viral infection of human cells in tissue culture (69) . It might, of course, be advantageous to use human cells as a source of interferon, but the same taboos would probably apply as do those in the manufacture of poliovirus vaccines. Manifestly, rigorous safety requirements must be met before any commercial interferon preparation would be acceptable. However, it seems likely from preliminary animal and human tests that preparations of sufficient purity will be innocuous.
The principle behind the use of interferon for treatment of viral diseases is basically sound. Although interferon is formed during the course of many viral infections, this endogenous source may be insufficient. Judicious administration of exogenous interferon, to compensate for any deficiency in production by the patient's own cells, could theoretically tip the balance in favor of the host. An alternative procedure might be to ad-minister an attenuated virus, one proven to have the capacity to stimulate production of endogenous interferon more rapidly and in larger quantities than the virus causing the patient's disease. There is evidence, for example, that individuals fed attenuated poliovirus vaccine of of one type may be protected against disease caused by another type (28) . Such attenuated polioviruses induce formation of interferon in tissue culture (36) .
Despite these cogent theoretical considerations for a rational therapy of viral diseases, it would be wise to reserve judgment about the practical efficacy and widespread applicability of interferon as a therapeutic agent. The difficulty would seem to lie in the nature of the pathogenetic processes in most acute viral diseases. When a patient presents himself to the physician, his viral infection may well have reached the state of irreversibility. It is entirely likely that the appearance of symptoms occurs at a time when virus titers have reached their peak, and the maximal number of cells are already committed. Exogenous interferon may not be capable of reversing cellular damage. Progression of disease beyond this stage may proceed by mechanisms other than virus multiplication, such as secondary tissue reactions (58), which would not respond to interferon or, for that matter, any chemotherapeutic agent.
For these reasons, it seems likely that the discovery of interferon may contribute more to theoretical understanding of the pathogenesis of viral diseases than to practical therapeutics. Certainly, research in this field is serving to focus attention on the intrinsic cellular factors in resistance to and recovery from viral infections. The available evidence points to a more significant role of the infected cells themselves than to humoral factors or to cells with special functions.
It should also be pointed out that interferon may indirectly be an important factor in humoral defense mechanisms of the host as well as serving to control local tissue infections. As suggested previously, "interference at a distant site" can best be explained on the basis of blood-stream transport of interferon from infected cells to distant uninfected tissues (27, 32). Of special interest in this regard is the finding that human leukocytes produce and release abundant amounts of interferon in response to infection in vitro with several viruses (24) . In these studies leukocytes from normal individuals and patients with various disorders, including hypogammaglobulinemia, were shown to be capable of forming interferon 12 hr to several days after infection with Sendai or measles virus. These observations are being extended to studies on natural recovery from systemic viral infections, particularly measles (Gresser, personal communication). If these experiments are successful, they may bring evidence to bear on the longsought-for role that leukocytes (mononuclear leukocytes?) are thought to play in viral infection, other than as phagocytic cells (16) .
No discussion of cellular resistance to viral infections would be complete without a comparison to specific immunity. As anticipated, the discovery of interferon has again raised the recurrent question whether antibody plays any significant role in recovery from acute viral infections (4, 15, 18) . The evidence suggests that antibody subserves a minor and secondary function. This is not to gainsay the benefits to be derived from immunization, either through natural infection or vaccination, in favorably influencing the outcome of infection on re-exposure to a virus. However, it is a common observation that patients usually recover from the effects of primary viral infections before any antibody can be detected in the blood. Conversely, infections such as measles may progress despite abundant supplies of circulating antibody (15) . Clinical observations of children with hypogammaglobulinemia also suggest that antibody is not the only factor in host resistance, as was once thought. Good and his associates (23), among others, have noted that these children do not usually have more severe viral infections than do immunologically competent children. Moreover, second attacks of measles and chickenpox are rare in children with hypogammaglobulinemia despite their enhanced susceptibility to repeated bacterial infections. It is also of interest that cortisone inhibits the production and action of interferon (53) (4) . These distinguishing characteristics serve to emphasize the differences between humoral immunity and cellular resistance.
